Adam V Wisnewski Selected Research

SARS-CoV-2 spike protein

1/2022	Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
1/2021	Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam V Wisnewski Research Topics

Disease

19	Asthma (Bronchial Asthma) 01/2024 - 05/2002
13	Occupational Asthma 01/2022 - 09/2003
8	COVID-19 01/2023 - 12/2020
4	Infections 01/2022 - 01/2021
4	Inflammation (Inflammations) 04/2015 - 05/2002
3	Eosinophilia 01/2020 - 05/2002
2	Disease Progression 01/2021 - 12/2020
1	Breakthrough Infections 01/2022
1	Occupational Diseases (Occupational Disease) 01/2019
1	Neoplasms (Cancer) 05/2017
1	Hematologic Neoplasms (Hematological Malignancy) 05/2017
1	Hypersensitivity (Allergy) 10/2011
1	Long Term Adverse Effects 05/2003
1	Pneumonia (Pneumonitis) 05/2002

Drug/Important Bio-Agent (IBA)

11	4,4'-diphenylmethane diisocyanate (methylene diphenyl diisocyanate)IBA 01/2024 - 05/2010
9	Immunoglobulin G (IgG)IBA 01/2022 - 04/2007
7	Polyurethanes (Polyurethane)IBA 06/2020 - 04/2007
6	IsocyanatesIBA 04/2015 - 09/2003
5	VaccinesIBA 01/2023 - 01/2021
5	AntigensIBA 01/2021 - 05/2002
5	Immunoglobulin E (IgE)IBA 01/2020 - 10/2006
4	AllergensIBA 01/2024 - 03/2013
3	EnzymesIBA 01/2022 - 04/2007
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2003
3	1,6-hexamethylene diisocyanate (hexamethylene diisocyanate)IBA 01/2018 - 05/2003
3	Glutathione (Reduced Glutathione)IBA 04/2015 - 10/2011
3	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 02/2012 - 10/2006
3	AlbuminsIBA 03/2011 - 06/2004
2	ChemokinesIBA 01/2024 - 01/2020
2	SARS-CoV-2 spike proteinIBA 01/2022 - 01/2021
2	Neutralizing AntibodiesIBA 07/2021 - 01/2021
2	mRNA VaccinesIBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 05/2010
2	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 06/2013 - 03/2011
1	OvalbuminIBA 01/2024
1	ChitinasesIBA 01/2024
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	EpitopesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Peptides (Polypeptides)IBA 05/2018
1	Alkylating AgentsIBA 05/2017
1	laromustine (VNP40101M)IBA 05/2017
1	DNCOIBA 11/2016
1	Elastomers (Elastomer)IBA 06/2013
1	polyurethane foamIBA 06/2013
1	diphenylmethaneIBA 04/2007
1	TolueneIBA 04/2007
1	ImmunosorbentsIBA 04/2007
1	Carrier Proteins (Binding Protein)IBA 10/2006
1	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2003
1	Sulfhydryl Compounds (Thiols)IBA 05/2003
1	CytokinesIBA 05/2002

Therapy/Procedure

1	Therapeutics 01/2021
1	Personal Protective Equipment 10/2012
1	Mechanical Ventilators (Ventilator) 10/2012